With appreciation from Edulink’s founders
As we reflect on our humble beginnings, we couldn’t have imagined 25 years later, having over 500 school districts, intermediate units, charter and technical schools across the state of Pennsylvania using our products. We are incredibly grateful to our clients for entrusting us to build software tools that address the unique compliance and evaluation management needs of educators. Much has changed over the last 25 years with safety, technology, regulations, and the way we educate, and we are honored to evolve and grow with you. Client support and feedback has been critical to our success, and we couldn’t be more appreciative of being along this journey with you. We’re excited to see what the next 25 years will bring!
Dr. David Myers and Dr. Reed Hankinson
EduLink, Inc. is an organization built around the spirit of helping others.
In some ways, that’s doing our part to bring quality software solutions to educators. But, in other ways, it’s serving and empowering others. That’s why we’ve partnered with Beverly’s Birthdays, a Pittsburgh organization that provides birthday cheer and critical baby care items for families in need or experiencing homelessness. Through the work of Beverly’s Birthdays and the programs they offer, 31,000 birthdays are celebrated annually!
EduLink is extremely proud to partner with Malayaka House, an orphanage for abandoned and abused children in Uganda. Edulink supports Malayaka House in many ways. Over the years, we have provided financial support and advice on various ventures. In particular, we have helped Malayaka House establish an IT department and computer lab.
EduLink is also a proud sponsor of A Night to Remember, a fantastic evening of dinner, dancing and enjoying friends for people ages 16-40 with developmental, physical, and mental delays. We couldn’t be more honored to be part of this special evening!
Each year, EduLink donates to and supports the mission of the Clear Thoughts Foundation. The purpose of the foundation is to raise funds for the discovery of drugs and therapeutics to help stop the progression of dementia and eventually the disease.